Authors


Chiara Rafanelli, MD

Latest:

Depression, Stress and the Risk of Heart Disease

In recent years, depression and stress have emerged in the discussion of the impact of psychosocial aspects on coronary heart disease. Several studies indicate that these factors result in risk elevation comparable to hypercholesterolemia and hypertension.


Chih-chiang Chiu, MD

Latest:

The Use of Omega-3 Fatty Acids in Treatment of Depression

This review provides an overview of the efficacy, safety, and mechanisms of action in the treatment of depression.


Chloe Campbell, PhD

Latest:

Trait Stages of Diagnosis for Borderline Personality Disorder

The authors describe an alternative model for BPD diagnosis that is dimensional in nature and requires fulfillment of 4 of 7 personality traits.


Chris Aiken, MD

Latest:

New Directions for Insomnia and Bipolar Disorder

The average patient with bipolar disorder struggles with sleep disorders. Here's how you can help.


Chris Bullen, MBChB, MPH, PhD

Latest:

The Role of Electronic Cigarettes for Tobacco Dependence Treatment

Stopping smoking affects the metabolism of a number of drugs used in the management of mental illness. Here, a summary of the author's published study on whether e-cigarettes with nicotine were more effective for smoking cessation than nicotine patches.


Chris Candler, MD

Latest:

In Support of Early Psychotherapy Training

Recent reports have noted an alarming decrease in the practice of psychotherapy among psychiatrists.


Chris E. Stout, PsyD

Latest:

Fee Agreements: What Works, What Doesn’t- and How to Use Them

This article reviews the many forms of fee agreement and notes the important factors to consider as well as questions to ask to properly assess and vet what may be best for one’s practice.


Chris Fitzpatrick, MD

Latest:

Scene From The Fall: Mental Ward US Military Hospital, Nuremberg, Germany

Here we present an excerpt from a screenplay to commemorate the 70th anniversary of the liberation of the concentration camps.


Chris Gordon, MD

Latest:

Scared of Heights

I am scared of heights. As a psychiatrist, it’s faintly embarrassing to have such a phobia-but given that I live in a Boston suburb, not the Rockies, it’s a problem that hardly ever comes up. Ski lifts and I don’t get along all that well, but other than that, I barely ever think of this as an issue in my life.


Chris Lang, MD

Latest:

Climate Change and Mental Health

The effects of climate change are severe and global, affecting world economies, triggering migrations and wars, and having profound effects on mental and physical health.


Christen E. Dressel, MA

Latest:

Treating Complex Trauma Survivors

This CME outlines distinguishing features of PTSD, complex trauma, and the dissociative subtype of PTSD (DPTSD), with an explanation of the distinctive neurobiological subtype of DPTSD.


Christian J. Nelson, PhD

Latest:

Cognitive Impairment in Patients Receiving Cancer Chemotherapy

Anxiety and depression are the most often cited problems related to a cancer diagnosis, because receiving this diagnosis is often very frightening. Feeling sad, worrying relentlessly, and being unable to experience pleasure often lead people to feel that they may be on the path to losing their minds. However, in the past few years a more subtle phenomenon has been identified related to cognitive deficits allegedly associated with chemotherapy treatment, sometimes called chemobrain.


Christina Brezing, MD

Latest:

Treatment for Cannabis Use Disorders: A Case Report

It is vital that psychiatrists are able to identify and characterize cannabis use disorders; provide education; and offer effective, evidence-based treatments. This article provides a brief overview of each of these topics.


Christina C. Sanchez, MA

Latest:

Cognitive-Behavioral Therapy for Adolescent DepressionProcesses of Cognitive Change

The substantial and often recurrent distress and impairment associated with major depressive disorder (MDD) in youth has prompted increased interest in the identification and dissemination of effective treatment models. Evidence supports the use of several antidepressant medications, specific psychotherapies, and, in the largest treatment study of depressed teenagers, the combination of fluoxetine and cognitive-behavioral therapy (CBT) as effective treatments.1-3 CBT is the most extensively tested psychosocial treatment for MDD in youth, with evidence from reviews and meta-analyses that supports its effectiveness in that population.3-5


Christina E. Wierenga, PhD

Latest:

Neurobiology of Eating Disorders: Clinical Implications

New insights into neural pathways that play a role in anorexia nervosa, bulimia nervosa, and binge eating disorder.


Christina L. Boisseau, MA

Latest:

Development of a Transdiagnostic Unified Psychosocial Treatment for Emotional Disorders

Research emerging from the field of emotion science suggests that individuals who have anxiety and mood disorders tend to experience negative affect more frequently and more intensely than do healthy individuals, and they tend to view these experiences as more aversive, representing a common diathesis across anxiety and mood disorders.1-5 Deficits in the ability to regulate emotional experiences, resulting from unsuccessful efforts to avoid or dampen the intensity of uncomfortable emotions, have also been found across the emotional disorders and are a key target for therapeutic change.


Christina L. Wichman, DO

Latest:

Speaking Up: Sexual Harassment in the Medical Setting

Here: a review of the definition of sexual harassment, its prevalence among physicians and medical students, its potential impact on physicians and trainees, and guidance about its management.


Christina S. Won, PharmD, PhD

Latest:

Mini Quiz: Dietary Effects of Psychiatric Drugs

How do foods containing tyramine (eg, aged cheeses, fermented foods, cured meats) interact with some psychiatric medications?


Christina Scribner, MS, RDN, CEDRD, CSSD

Latest:

Mini Quiz: Eating Disorders and Brain Function

What does the evidence tell us about the effect of eating disorders on brain function? Take the quiz and learn more.


Christina Thomas, MSSW

Latest:

Underdiagnosing and Overdiagnosing Psychiatric Comorbidities

Diagnostic assessment of psychiatric disorders and their comorbidities is a challenge for many clinicians. In emergency settings, there is no time to conduct lengthy interviews, and collateralinformation is often unavailable.


Christine E. Marx, MD

Latest:

Neurosteroids and Psychiatric Disorders

Although many of the physiological functions of neurosteroids are currently unknown, evidence suggests that these endogenous molecules may play a role in the pathophysiology of psychiatric disorders and treatment strategies. Neurosteroids have been linked to SSRI action and may be relevant to antipsychotic drug effects. Do neurosteroids have neuroprotective properties or HPA axis effects?


Christine E. Ryan, PhD

Latest:

Atypical Antipsychotic Augmentation in the Treatment of Depression

Despite the clinician's goal of treating the depressed patient to the point of remission, this state is generally achieved in only 15% to 30% of patients. Another 10% to 30% of patients respond poorly to antidepressant treatment, while 30% to 40% have a remitting and relapsing course.1 Patients without a major depressive disorder are likely to be treated successfully by primary care physicians and/or other mental health professionals, which leaves psychiatrists to treat patients who have forms of depression that are less responsive to treatment.


Christine Moutier, MD
Christine Yu Moutier, MD

Latest:

Preventing Clinician Suicide

Although the practice of medicine can be immensely rewarding, it also can be extraordinarily stressful. Here's how we can help prevent clinician suicide.


Christine Shapter, MD

Latest:

Depression and Anxiety in Cardiac Disease

Here: a look at the associations between negative psychological states and CV health, physiologic and health behavior mechanisms, and ways to diagnose and treat depression and anxiety disorders.


Christoph U. Correll, MD

Latest:

Reset the Clock on Schizophrenia: SPG302, A Regenerative Treatment

SPG302, a regenerative treatment for schizophrenia, could reset the clock on the brain.


Christopher Aloezos, MD

Latest:

The Butterfly Effect: An Interview With Jon Ronson

While ostensibly The Butterfly Effect tells the story behind the wide availability of free internet pornography, the psychiatrist listener will quickly appreciate that this is only the beginning of the story.


Christopher D. Webster, PhD

Latest:

Violence Risk Assessment in Everyday Psychiatric Practice

Hy Bloom provided an expert psychiatric report in a multiple murder case in which the accused, who had schizophrenia and depression, had killed his wife and 2 children. Before the murders, the accused had been seeing a psychiatrist and family physician for treatment of the mental disorders.


Christopher Daley, MD

Latest:

Working With Transgender Persons

Using a question-and-answer format, we present a brief overview of issues that arise when mental health professionals explore how to best serve this population.


Christopher Ferguson, PhD

Latest:

New Evidence Suggests Media Violence Effects May Be Minimal

New research over the past decade has suggested that links between media violence and child aggression are less clear than previously thought. How has our understanding of media violence effects changed?


Christopher G. Fichtner, MD

Latest:

Medical Marijuana and Mental Health: Cannabis Use in Psychiatric Practice

Here's why psychiatrists and other mental health professionals need to understand the relationship between cannabis and mental disorders.

© 2025 MJH Life Sciences

All rights reserved.